New antiepileptic drugs currently in clinical trials: is there a strategy in their development?
about
Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safetyLacosamide for the prevention of partial onset seizures in epileptic adults.Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.New antiepileptic drugs that are second generation to existing antiepileptic drugs.Valproic Acid: second generation.Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide.
P2860
New antiepileptic drugs currently in clinical trials: is there a strategy in their development?
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New antiepileptic drugs curren ...... strategy in their development?
@ast
New antiepileptic drugs curren ...... strategy in their development?
@en
New antiepileptic drugs curren ...... strategy in their development?
@nl
type
label
New antiepileptic drugs curren ...... strategy in their development?
@ast
New antiepileptic drugs curren ...... strategy in their development?
@en
New antiepileptic drugs curren ...... strategy in their development?
@nl
prefLabel
New antiepileptic drugs curren ...... strategy in their development?
@ast
New antiepileptic drugs curren ...... strategy in their development?
@en
New antiepileptic drugs curren ...... strategy in their development?
@nl
P1476
New antiepileptic drugs curren ...... strategy in their development?
@en
P2093
Meir Bialer
P356
10.1097/00007691-200202000-00015
P577
2002-02-01T00:00:00Z